Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Michael P. Morris Boehringer Ingelheim Corporation patentsThe following is a sampling of recent Michael P. Morris Boehringer Ingelheim Corporation patent applications (USPTO Patent Application #, Patent Title) sorted by month.
July 2008 - Michael P. Morris Boehringer Ingelheim Corporation patents
20080177029 - Process for preparing macrocyclic compounds
20080177066 - Process for the manufacture of dihydropteridinones
20080171747 - Intermediate compounds for making dihydropteridinones useful as pharmaceutical compositions
20080171749 - 1-phenyl-1,2-diaminoethane derivatives as modulators of the chemokine receptor activity
20080167298 - Medicaments for the treatment of chronic obstructive pulmonary disease
20080160046 - Gm-negative ehv-mutants
20080160076 - Two-part capsule to accept pharmaceutical preparations for powder inhalers
20080161297 - Rho kinase inhibitors
June 2008 - Michael P. Morris Boehringer Ingelheim Corporation patents
20080153833 - Substituted pteridines for the treatment of inflammatory diseases
20080145422 - Galantamine tablet formulation
20080146539 - New carboxylic acid amides, the preparation thereof and their use as medicaments
20080146543 - Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats
20080146554 - Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament
20080146628 - Pramipexole for the treatment of adhd
20080146639 - Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
20080139495 - Pharmaceutical composition of antiviral agents
20080139537 - Cgrp antagonists
20080139541 - Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compounds
20080139591 - Cgrp antagonists
20080139605 - Substituted prolinamides, manufacturing, and the use thereof as medicaments
20080131967 - Keratinocytes useful for the treatment of wounds
20080131969 - Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product
20080132493 - Highly concentrated stable meloxicam solutions for needleless injection
20080132496 - Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions
20080132556 - 3-hydroxymethyl-4hydroxy-phenyl- derivatives for the treatment of respiratory diseases
May 2008 - Michael P. Morris Boehringer Ingelheim Corporation patents
20080124760 - Regulatory nucleic acid elements
20080119482 - Method for the treatment of attention deficit hyperactivity disorder
20080119490 - Viral polymerase inhibitors
20080119523 - 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1h-benzimidazol-5- carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament
20080112980 - Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof
20080113023 - Bilayer tablet comprising telmisartan and diuretic
20080113871 - Assays useful in determining cd38 inhibition
20080113934 - Use of dipyridamole or mopidamol for treatment and prevention of fibrin-dependent microcirculation disorders
20080113949 - Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention
20080113992 - Dihydropteridione intermediate compounds
20080114024 - 1,6 naphthyridines useful as inhibitors of syk kinase
20080114046 - Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
20080114068 - Benzoic acid derivatives as non nucleoside reverse-transcriptase inhibitors
20080107731 - Dpp iv inhibitor formulations
20080108107 - Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
20080108788 - Recombinant c140 receptor, it's agonists and antagonists, and nucleic acids encoding the receptor
20080108812 - Dihydropteridione intermediate compounds
20080102037 - Stable pharmaceutical budesonide preparation for producing propellant-free aerosols
20080102479 - Method of diagnosing lawsonia intracellularis
20080103134 - Use of selected cgrp-antagonists in combination with other antimigraine drugs for the treatment of migraine
20080103138 - Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
20080103155 - Pharmaceutical compositions for the treatment of sexual disorders ii
20080103161 - Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
April 2008 - Michael P. Morris Boehringer Ingelheim Corporation patents
20080096832 - Method for improving the pharmacokinetics of an nnrti
20080096882 - Dihydrothienopyrimidines for the treatment of inflammatory diseases
20080097359 - Atomizer for applying liquids onto eyes
20080089849 - Powders for inhalation
20080089881 - Treatment and diagnostics of inflammatory diseases
20080090819 - Derivatives of [6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide
20080086003 - Crystalline compounds
20080081802 - Thiazolyl-dihydro-indazole
20080081822 - Compounds which modulate the cb2 receptor
20080082156 - Controlled release endoprosthetic device
March 2008 - Michael P. Morris Boehringer Ingelheim Corporation patents
20080076786 - Use of radical-scavenging compounds for treatment and prevention of no-dependent microcirculation disorders
20080076934 - (r)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1- (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition
20080066530 - Method for the optimization of chromatographic purification processes for biological molecules
20080069873 - Controlled release system and method for manufacturing the same
20080070909 - Enantiomerically pure beta agonists, manufacturing and use thereof
20080071064 - Tempering
20080063608 - Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid, and betamimetic
20080053430 - Aerosol formulation for the inhalation of beta agonists
20080057003 - Powder inhaler formulations
20080058257 - Costimulatory molecules and uses thereof
20080058379 - Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
February 2008 - Michael P. Morris Boehringer Ingelheim Corporation patents
20080051392 - Pharmaceutical combinations for the treatment of respiratory diseases
20080051443 - Compounds for the reduction of excessive food intake
20080051444 - Compounds for the reduction of excessive food intake
20080051578 - Substituted biaryls, process for their manufacture and use thereof as medicaments
20080041370 - Aerosol formulation for the inhalation of beta agonists
20080041369 - Aerosol formulation for the inhalation of beta agonists
20080041387 - Impaction nozzle for propellant driven metered dose aerosols
20080044361 - Hfa suspension formulations containing an anticholinergic
20080045443 - Compositions for inhibiting plexin-a1-dap12 interactions and methods of treating inflammatory, autoimmune or bone resorption diseases using the same
20080045516 - Viral polymerase inhibitors
20080045705 - production method
20080038346 - Extended release tablet formulations of flibanserin and method for manufacturing the same
20080038347 - Extended release tablet formulations of flibanserin and method for manufacturing the same
20080038357 - Inhalation powder containing the cgrp antagonist bibn4096 and process for the preparation thereof
20080039391 - New indications for direct thrombin inhibitors in the cardiovascular field
20080039464 - Compounds which modulate the cb2 receptor
20080031828 - Method for the treatment of dyspnea comprising combined administration of tiotropium salts and salts of salmeterol
20080031945 - Gastro retentive delivery system
20080033391 - Two-chamber cartridge for propellant-free metering aerosols
January 2008 - Michael P. Morris Boehringer Ingelheim Corporation patents
20080025919 - Benzoylguanidine salt and hydrates thereof
20080020987 - Processes for preparing pyrazole-o-glycoside derivatives and novel intermediates of said processes
20080021075 - Treatment of pain
20080021076 - Treatment of pain
20080011293 - Stable xylometazoline and oxymetazoline solution
20080011750 - Container provided with a pressure equalization opening
20080015176 - New paediatric indications for direct thrombin inhibitors
20080015178 - Benzimidazoles, process for their preparation and use thereof as medicament
20080015785 - Mass spectrometry algorithm
20080008720 - Substituted tricyclic heterocycles and their uses
20080009476 - Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva
20080009548 - Ambroxol for the treatment of acute pain
20080009617 - 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1h)-on
December 2007 - Michael P. Morris Boehringer Ingelheim Corporation patents
20070298116 - Amorphous, spray-dried powders having a reduced moisture content and a high long term stability
20070293494 - 2-anilino-4-(heterocyclic) amino-pyrimidines
20070293525 - 2-anilino-4-aminoalkyleneaminopyrimidines
20070293533 - Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
20070287704 - Substituted pteridines
20070281905 - Use of simethicone in constipated patients
20070281940 - Uses of dpp-iv inhibitors
November 2007 - Michael P. Morris Boehringer Ingelheim Corporation patents
20070275946 - Cytokine inhibitors
20070275951 - Selected cgrp-antagonists, process for preparing them and their use as pharmaceutical compositions
20070270401 - Thiazolyl-dihydro-indazole
20070264263 - Compositions for inhibiting sema7a and vla-1 interaction and the methods of using the same
20070265276 - Use of flibanserin for the treatment of post-menopausal sexual desire disorders
20070257134 - System comprising a nozzle and a fixing means therefor
20070259821 - Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
20070259846 - Compounds for the treatment of inflammatory diseases
20070259855 - Thiazolyl-dihydro-indazole
20070259900 - Polymorphs
October 2007 - Michael P. Morris Boehringer Ingelheim Corporation patents
20070249544 - Crystalline form of 1-chloro-4-(beta-d-glucopyranos-1-yl)-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
20070249592 - Use of selected cgrp antagonists in treatment and prevention of hot flushes in prostate cancer patients
20070249595 - Novel enantiomeric pure beta agonists, manufacturing and use as a medicament thereof
20070249629 - Viral polymerase inhibitors
20070249656 - Hfa suspension formulations containing an anticholinergic
20070240713 - Inhaler
20070243166 - Hepatitis c inhibitor compounds
20070244099 - Cgrp antagonists
20070244104 - Thiazolyl-dihydro-quinazoline
20070244176 - Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1h-pyrazol-3'-o-beta-d-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments
20070237773 - Human sema4a protein antibodies and uses thereof
20070237823 - Solid pharmaceutical form comprising and ltb4 antagonist
20070238715 - Selected cgrp-antagonists, process for preparing them and their use as pharmaceutical compositions
20070238718 - Thiazolyl-dihydro-indazole
20070238730 - Thiazolyl-dihydro-cyclopentapyrazole
20070238746 - Thiazolyl-dihydro-chinazoline
20070238860 - Method for refolding a protein
20070231272 - Process for preparing inhalable powders
20070232799 - Process for preparing 6-aryl-4h-s-triazolo[3,4-c]-thieno[2,3-e]-1,4-diazepines
September 2007 - Michael P. Morris Boehringer Ingelheim Corporation patents
20070221213 - Dosage aerosols for the application of pharmaceutical formulations
20070221535 - Package for multiple dose inhalators having optimised emptying properties
20070224267 - Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
20070225317 - Rsv polymerase inhibitors
20070219176 - Viral polymerase inhibitors
20070219369 - Process for the manufacture of fused piperazin-2-one derivatives
20070212717 - Method for inhibiting hepatitis c virus replication
20070212754 - Hepatitis c virus ns2/3 activity assay
20070213528 - Process for the manufacture of fused piperazin-2-one derivatives
20070213529 - Process for the manufacture of fused piperazin-2-one derivatives
20070213530 - Intermediate compounds for the manufacture of fused piperazin-2-one derivatives
20070213531 - Process for the manufacture of fused piperazin-2-one derivatives
20070213534 - Process for the manufacture of fused piperazin-2-one derivatives
20070207168 - Use of vaccines for the treatment/prevention of the transmission of pathogens
20070207999 - New compounds
20070208027 - Intermediate compounds for the manufacture of fused piperazin-2-one derivatives
20070208036 - Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them
20070208060 - Compounds for treating inflammatory diseases
August 2007 - Michael P. Morris Boehringer Ingelheim Corporation patents
20070202541 - Test system for measuring the interaction of stat 6 with ncoa-1
20070203125 - Medicament combinations for the treatment of respiratory diseases
20070203141 - Method for administering birb 796 bs
20070203146 - Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
20070196473 - Pharmaceutical compositions containing flibanserin
20070196900 - Method for the manufacture of lantibiotics
20070197503 - Solutions containing epinastin
20070197666 - Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention
20070191300 - Methods for modulating ikkalpha activity
20070191340 - Compounds which modulate the cb2 receptor
20070183982 - Pharmaceutical composition for aerosols with two or more active substances and at least one surfactant
20070185081 - Bicyclic heterocylces, pharmaceutical compositions containing these compounds, their use and processes for preparing them
20070185082 - Treating rhinitis by topically administering an epinastine solution to the nasal mucous membrane
20070185091 - Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
20070185173 - Process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides
20070185333 - Process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
20070178157 - Process for cleaning hard gelatine capsules
July 2007 - Michael P. Morris Boehringer Ingelheim Corporation patents
20070172936 - Purified active hcv ns2/3 protease
20070173517 - Synthesis of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides
20070166330 - Gm-negative ehv-mutants without heterologous elements
20070160604 - Methods of identifying compounds capable of modulating t cell immune responses involving sema4a protein
20070160629 - Purified active hcv ns2/3 protease
20070160665 - Chlorthalidone combinations
20070161054 - Methods and compositions for targeting secretory lysosomes
20070155679 - Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
20070155724 - Methods of treating cytokine mediated diseases
20070155741 - Medicaments for the treatment of chronic obstructive pulmonary disease
20070155773 - Use of tiotropium salts in the treatment of moderate persistent asthma
June 2007 - Michael P. Morris Boehringer Ingelheim Corporation patents
20070149490 - process for the extraction of betulinic acid
20070149589 - Process for the preparation of 4-(benzimidazolylmethylamino)benzamidines
20070149820 - Method for generating secondary phosphines
20070141701 - Hepatitis c virus ns2/3 assay
20070142354 - Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
20070142371 - Anti-cytokine heterocyclic compounds
20070142380 - Viral polymerase inhibitors
20070142383 - Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
20070135446 - Benzoylguanidlne salt and hydrates thereof
20070128123 - Tiotropium containing hfc solution formulations
20070128125 - Pharmaceutical compositions based on tiotropium salts and salts of salmeterol
20070128648 - Methods for the identification of ikkalpha function and other genes useful for treatment of inflammatory diseases
20070129435 - Pharmaceutical composition for treating stress incontinence and/or mixed incontinence
20070129542 - Process for making 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-di pyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
20070129673 - Dual chamber container and process for its filling up
May 2007 - Michael P. Morris Boehringer Ingelheim Corporation patents
20070122349 - Measuring particle size distribution in pharmaceutical aerosols
20070123516 - Method of treating mucus hypersecretion
20070123540 - Sexual desire enhancing medicaments comprising benzimidazolone derivatives
20070117788 - Combination of a dopamine d2-receptor agonist and tiotropium or a derivative therof for treating obstructive airways and other inflammatory diseases
20070107722 - Needle for piercing a powder capsule for inhalation
20070110679 - Process for determining the particle size distribution of an aerosol and apparatus for carrying out such a process
20070111981 - New (hetero)aryl compounds with mch antagonistic activity and medicaments comprising these compounds
20070112010 - Use of pde iii inhibitors for the treament of asymptomatic (occult) heart failure
20070112033 - Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
20070112191 - Process for the manufacturing of pharmaceutically active compounds
20070105753 - Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors
20070105857 - Process for making heteroaryl amine intermediate compounds
20070105869 - Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
20070105906 - Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
20070099832 - Combination therapy with p38 map kinase inhibitors and their pharmaceutical compositions
20070099903 - Selected cgrp antagonists, processes for preparing them and their use as pharmaceutical compositions
20070099907 - Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions
20070099918 - Use of inhibitors of the egfr-mediated signal transduction for the treatment of benign prostatic hyperplasia (bph) / prostatic hypertrophy
20070099949 - Method for improving the ability of patients suffering from lung diseases to participate in and benefit from pulmonary rehabilitation programs
20070099974 - (r)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition
20070100142 - Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
April 2007 - Michael P. Morris Boehringer Ingelheim Corporation patents
20070090576 - Process for forming a container opening
20070092453 - Novel crystalline forms of tiotropium bromide
20070093541 - Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
20070086951 - Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
20070086957 - Combination of medicaments for the treatment of respiratory diseases
20070088030 - Aerosol formulations for the inhalation of beta-agonists
20070088038 - 2-amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions
20070088051 - Indolinones and their use as antiproliferative agents
20070088160 - Process for the manufacturing of betamimetics
20070088174 - Synthesis of phenoxyacetic acid derivatives
20070089176 - Cytokine involved in epithelial-mesenchymal transition
20070082917 - Use of radical-scavenging compounds for treatment and prevention of no-dependent microcirculation disorders
20070077207 - Method for the production of propellant gas-free aerosols from aqueous medicament preparations
20070077296 - Pharmaceutical preparation containing meloxicam
20070078181 - Use of a beta-3-agonist for the treatment of patients with spinal cord injury and suffering from renal and bladder complaints
March 2007 - Michael P. Morris Boehringer Ingelheim Corporation patents
20070049537 - Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
20070049581 - Selected cgrp antagonists, processes for preparing them and their use as pharmaceutical compositions
February 2007 - Michael P. Morris Boehringer Ingelheim Corporation patents
20070041911 - Hfc solution formulations containing salbutamol hydrochloride or salbutamol citrate
20070043055 - Dihydropteridinones in the treatment of respiratory diseases
20070037781 - Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient
20070037986 - Preparation of 1,7,'-dimethyl-2'-propyl-2,5'-bi-1h-benzimidazole
20070031347 - Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
20070032403 - Crystal structure of the itk kinase domain
20070032473 - Substituted amides and their use as medicaments
20070032492 - Cytokine inhibitors
20070032514 - 2,4-diamino-pyrimidines as aurora inhibitors
20070032516 - Use of tiotropium salts in the treatment of severe persistent asthma
20070032654 - Stable polymorph of flibanserin
20070032655 - Stable polymorph of flibanserin
20070027092 - Glucopyranosyl-substituted ((hetero)cycloalkylethynyl-benzyl)-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
20070027148 - New enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments
20070027168 - 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals
20070027170 - Process for preparing amino crotonyl compounds
20070027320 - New process for the production of tiotropium salts
January 2007 - Michael P. Morris Boehringer Ingelheim Corporation patents
20070014848 - Resorbable polyetheresters and medicinal implants made therefrom
20070015203 - Infectious bovine viral diarrhea virus
20070015749 - Use of substituted pteridines for the treatment of respiratory diseases
20070015785 - Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
20070009498 - Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
20070003991 - Method of diagnosing lawsonia intracellularis
20070004648 - Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
20070004684 - Alpha-carbolines as cdk-1 inhibitors
20070004687 - Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ll antagonist for stroke prevention
20070004720 - Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
20070004757 - Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
December 2006 - Michael P. Morris Boehringer Ingelheim Corporation patents
20060292084 - Process for cleaning hard gelatine capsules
20060293292 - Methods of using acyl hydrazones as seh inhibitors
20060293300 - New substituted thiophene carboxamides, process for their preparation and their use as medicaments
20060293306 - Viral polymerase inhibitors
20060286041 - Mrp iv inhibitors for the treatment of respiratory diseases
20060286123 - prrs vaccines
20060287376 - Palladium catalyzed indolization of 2-bromo or chloroanilines
20060287530 - Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
20060272638 - Dosing device and method for dosing
20060276441 - Medicaments comprising steroids and a novel anticholinergic
20060276453 - Anti-cytokine heterocyclic compounds
20060276496 - Anti-cytokine heterocyclic compounds
20060276513 - Polymorphs of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h- benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
20060276515 - Soluble epoxide hydrolase inhibitors and methods of using same
20060276526 - Crystalline form of telmisartan sodium
November 2006 - Michael P. Morris Boehringer Ingelheim Corporation patents
20060269991 - T cell protein and nucleotides encoding the same
20060270667 - Novel medicament combinations for the treatment of respiratory diseases
20060270671 - Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
20060270672 - Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
20060263431 - Opioid sustained release formulation
20060263841 - Fluorescent probes for use in protein kinase inhibitor binding assay
20060264450 - Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
20060264472 - Derivatives of 6,7-dihydro-5h-imidazo[1,2-a] imidazole-3-sulfonic acid
20060264511 - Method for the treatment of drug-induced sexual dysfunction
20060264512 - Method for the treatment of sexual dysfunction due to medical conditions
20060254584 - Powder inhaler
20060257475 - Stable sertraline hydrochloride formulation and method
20060258640 - Use of flibanserin in the treatment of chronic pain
20060258681 - 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
20060258749 - Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
20060258861 - Compounds for the treatment of inflammatory diseases
20060258868 - Hepatitis c inhibitor peptide analogs
20060258888 - Bis-amination of aryl halides
20060258993 - Atomizer for applying liquids onto eyes
20060251586 - Method for the administration of an anticholinergic by inhalation
20060251728 - Crystalline forms of 1-chloro-4-(beta-d-glucopyranos-1-yl)-2-[4-((r)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
20060252750 - Selected cgrp-antagonists, process for preparing them and their use as pharmaceutical compositions
20060252773 - Method for the treatment of drug abuse
20060252811 - Substituted benzylimidazoles useful for the treatment of inflammatory diseases
20060252931 - New cgrp-antagonists, process for preparing them and their use as pharmaceutical compositions
20060252951 - Process for continuous ringclosing metathesis in compressed carbondioxide
20060246009 - Novel crystalline forms of tiotropium bromide
20060246010 - Process for determining the particle size distribution of an aerosol and apparatus for carrying out such a process
20060246424 - Self-replicating rna molecule from hepatitis c virus
20060247226 - Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
20060247230 - Novel piperidine-substituted indoles
20060247278 - Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
October 2006 - Michael P. Morris Boehringer Ingelheim Corporation patents
20060237016 - Dry powder inhaler
20060239908 - Compositions for inhalation
20060239930 - Process for nebulizing aqueous compositions containing highly concentrated insulin
20060239935 - Compositions for inhalation
20060240041 - Prrsv vaccines
20060240499 - Methods for determining phosphoryltransferase activity using adenosine 5'-triphosphate (atp)-gamma-s
20060241089 - Dipyridamole, acetylsalicylic acid, and angiotensin ii antagonist pharmaceutical compositions
20060234946 - Use of telmisartan for the prevention and treatment of vascular headache
20060234953 - Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
20060235010 - Inhibitors of papilloma virus
20060235017 - Cytokine inhibitors
20060228305 - Pharmaceutical compositions based on anticholinergics and inhibitors of tnf alpha synthesis or action
20060229287 - Derivatives of [6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonyl]-azetidine-carboxylic acids, esters and amides
20060219242 - Method for the administration of an anticholinergic by inhalation
20060222598 - Aerosol formulation for inhalation comprising an anticholinergic
20060222599 - Inhalative powder formulations containing the cgrp-antagonist 1 [n2-[3,5-dibromo-n-[[4-(3,4-dihydro-2(1h)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4-pyridinyl)-piperazine
20060222640 - New pharmaceutical compositions for treatment of thrombosis
20060223759 - Substituted 1,2-ethylenediamines, methods for preparing them and uses thereof
20060223869 - Compounds for the reduction of excessive food intake
September 2006 - Michael P. Morris Boehringer Ingelheim Corporation patents
20060208084 - Method and system for assisted culling and reformatting of encoded microtubes
20060211685 - Pharmaceutical compositions for the treatment and/or prevention of depression
20060211873 - Synthesis of cyproterone acetate
20060204450 - Pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
20060204486 - Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
20060205033 - Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof
20060205638 - Process for preparing macrocyclic compounds
20060205711 - Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
20060205758 - Method for reducing the mortality rate
20060198887 - Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
20060198913 - Method of improvement of blood circulation
20060199805 - Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
20060199867 - Ambroxol for the treatment of chronic pain
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Michael P. Morris Boehringer Ingelheim Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Michael P. Morris Boehringer Ingelheim Corporation with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
